Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA 2025-02-21 00:01
Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development 2025-02-20 15:31
Nona Biosciences Announces Licensing Agreement with the University of Alabama at Birmingham to Support B Cell Development Research 2025-02-20 09:21
Brexogen and BMI Korea Enter Strategic Technology Transfer Agreement for Exosome Therapeutics 2025-02-19 21:00
Biosion, Inc. Appoints Kedan Lin, Ph.D., as Chief Development Officer and President of Biosion US 2025-02-19 19:39
WuXi Biologics Awarded Platinum Medal by EcoVadis Sustainability Rating for Second Consecutive Year 2025-02-18 17:00
SBTi Verifies GenScript Biotech Corp's Carbon Emission Reduction Goals, Marking a Major Sustainability Milestone! 2025-02-18 15:27
CJ Bioscience to Present Preclinical Data on Inflammatory Bowel Disease Pipeline Candidate CJRB-201 at 'ECCO 2025'; Clinical Entry Targeted for 2026 2025-02-18 15:00
IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health 2025-02-14 22:30
Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases 2025-02-14 21:56
Harbour BioMed Announces Business Progress and Update 2025-02-14 12:08
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States 2025-02-14 08:35
Accropeutics Announces First Patient Dosed in Phase Ib Study of RIPK2 Inhibitor AC-101 2025-02-13 18:53
Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa 2025-02-13 15:00
DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development 2025-02-13 13:40
Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC 2025-02-13 09:26
OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer 2025-02-12 21:00
Actinogen announces peer-reviewed clinical pharmacology manuscript for Xanamem (emestedastat) published in Clinical Pharmacology in Drug Development journal 2025-02-12 21:00
Samsung Biologics recognized for leadership band in water security 2025-02-12 20:00
Cathay Biotech to showcase thermoplastic bio-based composite materials (bio-PPA CFRT) at 2025 JEC World 2025-02-11 21:05
1 31 32 33 34 35 262